Bellericagenin A
Product Specifications
UNSPSC Description
Bellericagenin A is a pentacyclic triterpenic acid isolated from the bark of Terminalia bellerica. Bellericagenin A exhibits antimicrobial activity. Bellericagenin A exhibits a high affinity to alcohol dehydrogenase (ADH), which has the potential for ameliorating the alcoholic liver injury[1][2].
Target Antigen
Bacterial
Type
Natural Products
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/bellericagenin-a.html
Smiles
C[C@]12[C@]3(C([C@@]4([H])[C@@](CC3)(CCC(C)(C4)C)C(O)=O)=CC[C@]1([H])[C@@]5([C@@]([C@@](C)([C@H]([C@@H](C5)O)O)CO)([H])C[C@H]2O)C)C
Molecular Weight
504.70
References & Citations
[1]Mahato S B, et al., Pentacyclic triterpenoid sapogenols and their glycosides from Terminalia bellerica[J]. Tetrahedron, 1992, 48(12): 2483-2494.|[2]Banjan B, et al., Computational identification of potential bioactive compounds from Triphala against alcoholic liver injury by targeting alcohol dehydrogenase. Mol Divers. 2024 May 14.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-N13031/Bellericagenin-A-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-N13031/
Clinical Information
No Development Reported
CAS Number
141630-18-4
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items